innovation

Image credit: National Institutes of Health Technological advances have paved the way for researchers to access a wealth of data about the biological cause of disease. Yet translating these discoveries into treatments remains a challenge. Promising drugs often fail in late phase clinical trials, costing time and money, and leaving patients’€™ lives hanging in the balance. One reason is that the right biological targets were not chosen from the start. To improve the current model for developing new diagnostics and treatments, the National Institutes of Health (NIH) and several biopharmaceutical companies and non-profit organizations formed the Accelerating Medicines Partnership (AMP), www...
Dear Research Advocate: Today, Chairwoman Barbara Mikulski (D-MD) released the Senate’€™s 302(b) allocations , which were approved by the Appropriations Committee. As you know from last week, the House 302(b) allocation for the Labor-HHS subcommittee is approximately $1 billion less in fiscal year 2015 than it was in FY 14.The Senate’€™s allocation for FY 15 is roughly the same as it was in FY 14. The bottom line is that, as expected, we have our work cut out for us to achieve the increases needed for the National Institutes of Health (NIH) and our nation’€™s other health research agencies. Fortunately, Senator Mikulski and other leaders from both sides of the aisle understand the...
Dear Research Advocate: In recognition of his many accomplishments as a champion for research, Research!America Chair and former Congressman John Edward Porter was honored by the National Academy of Sciences with the Public Welfare Medal, the Academy’€™s most prestigious award. This well-deserved acknowledgment of Porter’€™s tireless efforts to advance innovation and engage scientists in advocacy should motivate advocates to follow his lead and speak up about threats to our nation’€™s research ecosystem. Read our statement on the award ceremony here . In his remarks , Mr. Porter noted that ’€œpolitical judgment should never be allowed to be substituted for scientific judgment.’€ This point...
Dear Research Advocate: The budget and appropriations process typically reveals stark differences in funding priorities among the two parties. And this year is no exception. House Budget Committee Ranking Member Chris Van Hollen (D-MD-08) introduced the Democrats’€™ 10-year budget plan this week, which stands apart from the Republican proposal introduced by Chairman Paul Ryan (R-WI-01) most notably by ending sequestration. The Ryan budget, which won House approval today, is on its way to the Senate but is considered dead on arrival. Note that there’€™s still time to urge your Members of Congress to support medical and health research as this year’€™s appropriations process continues! Teen...
Tell the House to Reject the House Majority’€™s Budget Plan In response to President Obama’€™s budget proposal, House Budget Committee Chairman Paul Ryan (R-WI-01) released a budget plan titled, ’€œThe Path to Prosperity.’€ In this 10-year budget, Rep. Ryan proposes drastic cuts to the funding used to support medical progress among other national priorities. If this budget became law, it is a near certainty that our nation would lose its global lead in science and innovation, undermining jobs, sabotaging any progress toward economic stability, and stalling research that is addressing deadly and disabling health threats. Research reduced cancer deaths among children by 2.1% per year from...
Excerpt of an article by Research!America VP of Communications Suzanne Ffolkes and Communications Specialist Anna Briseno, published in Elsevier Connect . A panel hosted by Research!America and the Pancreatic Cancer Action Network discusses challenges and opportunities for advancing cancer research Julie Fleshman’s journey to improve outcomes for pancreatic cancer patients was inspired by her father, who died four months after receiving the diagnosis. That was in 1999. Since then, she’s been advocating for research to support early diagnosis and better treatments. “That passion drives me every day ’€“ anger mixed with hope and optimism of the future,” she said. Fleshman , President and CEO...
Dear Research Advocate, Ironically, the government is closed down today. But that’€™s due to a major snowstorm, not because of failure to agree on increasing the debt limit! Agreeing to increase the debt limit is an encouraging sign that this Congress, weighed down as it is by ideological and political differences, and with record- low approval rankings from the public, can get its job done! Our job is to be sure research is a top priority in this election year ’€” spoken of with conviction by all candidates and by the media and others who influence them. Standing tall among Members of Congress who champion science are the Chair and Ranking Member of the House Appropriations’€™ Commerce,...
Reps. Wolf and Fattah to Receive the Edwin C. Whitehead Award for Medical Research Advocacy at Research!America’€™s Advocacy Awards Dinner on March 12 ALEXANDRIA, Va. - February 12, 2014 -Reps. Frank Wolf (R-VA) and Chaka Fattah (D-PA) will receive the Edwin C. Whitehead Award for Medical Research Advocacy for their leadership and unwavering commitment to supporting policies that promote federal and private sector medical research and innovation. Reps. Wolf and Fattah have spearheaded efforts to create a legislative and regulatory climate conducive to medical innovation. “Representatives Wolf and Fattah are exceptional champions for research,” said Research!America Chair John Edward Porter...
Dear Research Advocate: Since President Obama declared 2014 as a ’€œyear of action’€ in his State of the Union address, several people have asked my view on how the president might advance science by executive order. Some options that come to mind: the president can (1) pump up the budget for NIH and other science agencies in his FY15 budget blueprint, scheduled for release in early March; (2) require an assessment of the impact on innovation, access and economic growth before making any administration-initiated cuts to drug, biologic or device reimbursement; and (3) designate a task force to formulate a national science strategy. As several Members of Congress noted after the president’€™...
January 29, 2014 It’s heartening President Obama chose to emphasize in his speech the significance of federally funded basic research and the need to undo the damage that has been done to it in recent years with deep spending cuts. The president used language the science community epitomizes – he spoke of working for “breakthroughs” and a nation motivated by opportunity. But actions speak louder than words. Congress and the White House must treat research and innovation as the health and economic imperative it has always been and invest in expanding our nation’s research capacity. It bears on business and job creation in both the research and manufacturing sectors; it bears on our nation’s...

Pages

Sidebar Quote

Funding research gives all of us a better chance of living a healthier life.
Pam Hirata, heart disease survivor